And Zhang et al. reported that troglitazone (PPAR-γ agonist) depressed transforming growth factor-β1-(TGF-β1-) stimulated collagen type I expression and collagen synthesis in keloid fibroblasts in a concentration-dependent manner [12]. Here, TGFB1 is linked to keloid.